Dendreon to Open Atlanta Pharma Plant
Post Views 0Seattle, Washington’s Dendreon plans to construct a $70 million manufacturing facility near Atlanta, Georgia, creating hundreds of jobs.
The plant will manufacture Provenge, a treatment for patients with advanced prostate cancer. The drug is under review by the Food and Drug Administration, and the plant will open when the product is approved.
Dendreon is a biotechnology company that currently employs 250 people.
Dendreon to Open Atlanta Pharma Plant by Harrison Barnes